SVTR 硅谷科技评论SVTR
← Database
Total funding $4M📍 Munich · Western EuropeFounded 2023

Position in SVTR

Snapshot 2026-10-19
🔒 Sign in for the exact rank and neighbours

About

Dehaze, founded in 2023 in Munich, Germany, uses AI to analyze existing patient data to identify missed diagnoses, flag inappropriate treatments, and predict future health risks.

★ SVTR RatingSVTR has evaluated this company

Full tier & rationale — an SVTR Intelligence benefit

Capital graph

CompanyInvestorFounders / teamCo-investment (thicker arc = more shared deals, ×N marks the count)Bigger circle = stronger signal (activity / coverage / interest) · ⛶ fullscreen · scroll / pinch to zoom · hover to highlight · drag nodes · click a node to open its profile

Founders / core team

Investors

Funding history

Comparable companies· by market

In commonSimilar business · Same sector: Life Sciences

MostSimilar total funding

Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.

Investors that may fit

Y Combinator

38 Life Sciences deals in the last 24 months · 26 at a nearby stage · 5 in 西欧

Request intro →

Alumni Ventures

12 Life Sciences deals in the last 24 months · 8 at a nearby stage · 1 in 西欧

Request intro →

Accel

12 Life Sciences deals in the last 24 months · 8 at a nearby stage · 2 in 西欧

Request intro →

LifeX Ventures

8 Life Sciences deals in the last 24 months · 5 at a nearby stage · 1 in 西欧

Request intro →

Index Ventures

8 Life Sciences deals in the last 24 months · 4 at a nearby stage · 1 in 西欧

Request intro →

Redalpine

8 Life Sciences deals in the last 24 months · 5 at a nearby stage · 4 in 西欧

Request intro →

Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.

Want to reach Dehaze — for capital, customers, or partnership? Send a short request; SVTR reviews it and brokers the intro, with both sides verified before you meet.

Request an intro to this companySubscribe to Signal